Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)

ClinicalTrials.gov ID: NCT03852472

Public ClinicalTrials.gov record NCT03852472. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized , Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study to Evaluate the Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa

Study identification

NCT ID
NCT03852472
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
435 participants

Conditions and interventions

Interventions

  • Avacopan Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 20, 2018
Primary completion
Jan 13, 2021
Completion
Mar 8, 2021
Last update posted
Mar 16, 2025

2018 – 2021

United States locations

U.S. sites
91
U.S. states
30
U.S. cities
78
Facility City State ZIP Site status
Clinical Site Birmingham Alabama 35233
Clinical Site Birmingham Alabama 35244
Clinical Site Mobile Alabama 36608
Clinical Site Phoenix Arizona 85006
Clinical Site Scottsdale Arizona 85255
Clinical Site Fort Smith Arkansas 72916
Clinical Site Rogers Arkansas 72758
Clinical Site Fountain Valley California 92708
Clinical Site Fremont California 94538
Clinical Site Fullerton California 92821
Clinical Site Huntington Beach California 92647
Clinical Site Inglewood California 90301
Clinical Site Los Angeles California 90025
Clinical Site Los Angeles California 90045
Clinical Site Los Angeles California 90057
Clinical Site Manhattan Beach California 90266
Clinical Site Newport Beach California 92660
Clinical Site Northridge California 91324
Clinical Site Redwood City California 94063
Clinical Site Thousand Oaks California 91320
Clinical Site Walnut Creek California 94598
Clinical Site Boca Raton Florida 33486
Clinical Site Clearwater Florida 33765
Clinical Site Hialeah Florida 33016
Clinical Site Hollywood Florida 33021
Clinical Site Homestead Florida 33030
Clinical Site Miami Florida 33125
Clinical Site Miami Florida 33144
Clinical Site Miami Florida 33173
Clinical Site Ocala Florida 34470
Clinical Site Orlando Florida 32819
Clinical Site Pembroke Pines Florida 33028
Clinical Site Tampa Florida 33603
Clinical Site Tampa Florida 33614
Clinical Site Tampa Florida 33624
Clinical Site Weston Florida 33327
Clinical Site Atlanta Georgia 30322
Clinical Site Marietta Georgia 30060
Clinical Site Newnan Georgia 30263
Clinical Site Sandy Springs Georgia 30328
Clinical Site Boise Idaho 83713
Clinical Site Skokie Illinois 60077
Clinical Site Skokie Illinois 60640
Clinical Site Crown Point Indiana 46307
Clinical Site Evansville Indiana 47715
Clinical Site Indianapolis Indiana 46250
Clinical Site Louisville Kentucky 40217
Clinical Site Metairie Louisiana 70006
Clinical Site New Orleans Louisiana 70124
Clinical Site Largo Maryland 20774
Clinical Site Beverly Massachusetts 01915
Clinical Site Boston Massachusetts 02101
Clinical Site Quincy Massachusetts 94598
Clinical Site Clarkston Michigan 48346
Clinical Site Fort Gratiot Michigan 48059
Clinical Site Saint Joseph Michigan 49085
Clinical Site Troy Michigan 48084
Clinical Site Minneapolis Minnesota 55455
Clinical Site St Louis Missouri 63110
Clinical Site Omaha Nebraska 68144
Clinical Site Verona New Jersey 07044
Clinical Site New York New York 10012
Clinical Site Rochester New York 14623
Clinical Site Chapel Hill North Carolina 27516
Clinical Site Charlotte North Carolina 028277
Clinical Site Charlotte North Carolina 28209
Clinical Site Charlotte North Carolina 28277
Clinical Site Wilmington North Carolina 28401
Clinical Site Athens Ohio 45701
Clinical Site Bexley Ohio 43209
Clinical Site Cleveland Ohio 44106
Clinical Site Marion Ohio 43302
Clinical Site Mason Ohio 45040
Clinical Site Norman Oklahoma 73071
Clinical Site Portland Oregon 97210
Clinical Site Drexel Hill Pennsylvania 19026
Clinical Site Hershey Pennsylvania 17033
Clinical Site Philadelphia Pennsylvania 19104
Clinical Site Warwick Rhode Island 02886
Clinical Site Charleston South Carolina 29407
Clinical Site Nashville Tennessee 37215
Clinical Site Austin Texas 78660
Clinical Site Austin Texas 78745
Clinical Site Dallas Texas 75231
Clinical Site Houston Texas 77054
Clinical Site Houston Texas 77056
Clinical Site Houston Texas 77084
Clinical Site San Antonio Texas 78218
Clinical Site Sugar Land Texas 77027
Clinical Site Spokane Washington 99202
Clinical Site Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03852472, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03852472 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →